by Walter Gunzburg | Feb 3, 2023 | News
We have shown the incredible physical robustness of Cell-in-a-Box® capsules placed under compression forces using a piston (see video) and also the stability of capsules when they are injected through a needle. Cell-in-a-Box® capsules are also stable for many...
by Walter Gunzburg | Dec 21, 2022 | News
Austrianova/SGAustria is pleased to announce that during the last year it has made major progress and achieved some significant milestones. During 2022, as well as our ongoing projects, the Company has acquired three new partners all involved in cutting edge therapy...
by Walter Gunzburg | Nov 29, 2022 | News
‘ ”’ ‘ All therapeutics go through three phasese of clinical trial testing (phase 1, 2 and 3) before market authorization is possible and they are approved for use in patients. Because late stage clinical trials involve more subjects than early...
by Walter Gunzburg | Sep 16, 2022 | News
Austrianova Chief Production Officer speaking at Bio Asia Pacific 2022 about Austrianova’s GMP Cell Encapsulation and Cell Banking...
by Walter Gunzburg | Jun 30, 2022 | News
WARNING: it has come to our attention that persons unknown are impersonating Austrianova through job interviews and job offers via Austrianova.co (not our official address which is Austrianova.com). We are currently not hiring and we do NOT conduct any...
by Walter Gunzburg | Jul 12, 2021 | News
SINGAPORE, July 12th, 2021 Austrianova (the SG Austria group, Austrianova Singapore and Austrianova Thailand) is delighted to announce the appointment of Pierre Faddoul to the Austrianova management team as the company’s new Chief Financial Officer (CFO)....
